ICER Releases Final Report on Acute Treatments for Migraine
Sydney Otomancek2023-12-14T13:19:56-05:00February 26th, 2020|Categories: Featured, Industry News|Tags: Healtheconomics.com, HEOR, ICER, Institute for Clinical and Economic Review, market access, migraine, Reyvow, rimegepant, Ubrelvy|
The Institute for Clinical and Economic Review (ICER) on Tuesday, Feb. 25, released its final report on three acute treatments [...]
ICER Hosts Meeting on Migraine Treatments
Sydney Otomancek2023-12-14T13:20:55-05:00February 1st, 2020|Categories: Featured, Industry News|Tags: Allergan, Healtheconomics.com, HEOR, ICER, Institute for Clinical and Economic Review, market access, migraine, Ubrelvy|
The Institute for Clinical and Economic Review (ICER) hosted a public meeting last week to discuss new treatments for migraines. [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!